Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Daneman

Showing results (351-360 of 361) with videos related to

Pageof 37
Sort By:
JAMA|September 13, 2018
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical TrialPatrick N A Harris, Paul A Tambyah, David C Lye, et al.
Trials|May 5, 2021
Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trialPhilippe Bégin, Jeannie Callum, Nancy M Heddle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2023
Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch ProtocolDana de Kretser, Jocelyn Mora, Max Bloomfield, et al.
BMJ Open|July 17, 2025
Clinical evaluation of adults undergoing elective surgery utilizing intraoperative incisional wound irrigation (CLEAN Wound): protocol for a randomised controlled trialRachel Roke, Erin Lillie, Nick Daneman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2024
Effects of Losartan on Patients Hospitalized for Acute COVID-19: A Randomized Controlled TrialKaren C Tran, Pierre Asfar, Matthew Cheng, et al.
CMAJ Open|March 10, 2021
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort studySrinivas Murthy, Patrick M Archambault, Anika Atique, et al.
Critical Care Medicine|July 1, 2016
Influenza A (H1N1pdm09)-Related Critical Illness and Mortality in Mexico and Canada, 2014Guillermo Dominguez-Cherit, Alethse De la Torre, Asgar Rishu, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 20, 2022
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trialKarim Ali, Tanweer Azher, Mahin Baqi, et al.
The New England Journal of Medicine|November 20, 2024
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections, Nick Daneman, Asgar Rishu, et al.
The New England Journal of Medicine|June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia, Todd C Lee, Lauren A Barina, et al.
Pageof 37

Showing results (351-360 of 361) with videos related to

Sort By:
Pageof 37
JAMA|September 13, 2018
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical TrialPatrick N A Harris, Paul A Tambyah, David C Lye, et al.
Trials|May 5, 2021
Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trialPhilippe Bégin, Jeannie Callum, Nancy M Heddle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2023
Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch ProtocolDana de Kretser, Jocelyn Mora, Max Bloomfield, et al.
BMJ Open|July 17, 2025
Clinical evaluation of adults undergoing elective surgery utilizing intraoperative incisional wound irrigation (CLEAN Wound): protocol for a randomised controlled trialRachel Roke, Erin Lillie, Nick Daneman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2024
Effects of Losartan on Patients Hospitalized for Acute COVID-19: A Randomized Controlled TrialKaren C Tran, Pierre Asfar, Matthew Cheng, et al.
CMAJ Open|March 10, 2021
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort studySrinivas Murthy, Patrick M Archambault, Anika Atique, et al.
Critical Care Medicine|July 1, 2016
Influenza A (H1N1pdm09)-Related Critical Illness and Mortality in Mexico and Canada, 2014Guillermo Dominguez-Cherit, Alethse De la Torre, Asgar Rishu, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 20, 2022
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trialKarim Ali, Tanweer Azher, Mahin Baqi, et al.
The New England Journal of Medicine|November 20, 2024
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections, Nick Daneman, Asgar Rishu, et al.
The New England Journal of Medicine|June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia, Todd C Lee, Lauren A Barina, et al.
Pageof 37